No savings at 50? I’d buy these 2 FTSE 100 stocks to retire on a rising passive income

These two FTSE 100 (INDEXFTSE:UKX) dividend heroes could make your retirement more comfortable.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you haven’t built up much in the way retirement savings at age 50, you need to start playing catch-up today. I think the best way of doing this is to invest in equities using your annual Stocks and Shares ISA allowance.

This allows you to invest anything up to £20k in the stock market before 5 April, with all returns free of tax. I would start by investing in a balanced portfolio of FTSE 100 shares to generate growth and income. These two could be a good place to start.

GlaxoSmithKline

Pharmaceutical company GlaxoSmithKline (LSE: GSK) is a giant of a stock, with a market-cap of more than £92bn. Its three global businesses focus on pharmaceuticals, vaccines and consumer healthcare and spends around £4bn a year researching and developing a pipeline of new products, to keep the cash and profits flowing.

The Glaxo share price is now in revival mode, as I predicted this time last year, when I hailed it the ideal buy for uncertain times. It’s up around 25% since then.

Glaxo’s stock offers a solid dividend yield of around 4.3% a year, so the total return over the last year was closer to 30%. Despite that, it still looks a relative bargain, as its shares trade at around 15.3 times earnings, below the FTSE 100 average of 18.03 times.

Glaxo has frozen its dividend at around 80p in recent years, to pump more of its profits into R&D. Investors are now waiting to see whether that investment is going to pay off. The share price may not rise another 25% this year, but if investing for retirement, you have to look beyond that.

At age 50, you could hold this stock for another 30 years or so, and over such a lenghty period I believe GlaxoSmithKline will prove a rewarding investment for both growth and income.

Legal & General Group

Here’s another renowned FTSE 100 blue-chip stock I’d consider to generate a passive income. Asset manager and insurer Legal & General Group (LSE: LGEN) offers an even more generous yield than Glaxo, with a forecast income of 6.2% in the year ahead.

This is far above the FTSE 100 average of 4.34% and, crucially, it also looks sustainable, as it’s covered 1.8 times by company earnings.

The last 12 months have also been good for the Legal & General share price, which is up more than 20%. It’s enjoyed growth from the bulk annuity market, insuring risk on company pension schemes to ease the burden on employers.

The £18.62bn group has an incredible £1.2trn of assets under management, making it one of Europe’s biggest fund managers, yet trades at a bargain price of just 9.4 times earnings. You can buy the L&G share price for just half the FTSE 100’s valuation.

If equities have a bumpy year I’d seize the opportunity to load up on more L&G stock at the lower price, as part of your quest to build a portfolio of shares to deliver a rising passive income when you retire.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Suddenly investors can’t get enough of GSK shares! What’s going on?

After years in the doldrums, GSK shares are suddenly the most bought stock on the entire FTSE 100. Harvey Jones…

Read more »

'2024' art concept overlaid on a stock screener
Investing Articles

£5,000 invested in Greggs shares in October 2024 is now worth…

Despite facing a multitude of challenges today, might Greggs' stock be worth a look after losing well over a third…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Where will Rolls-Royce shares go next? Let’s ask the experts

Rolls-Royce shares have wobbled as aviation uncertainty grows. But can the City's glowing forecasts help get the price climbing again?

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

No savings at 45? Here’s how investors could still build a £17,360 second income

It’s never too late to start investing, and with compounding working over time, Andrew Mackie shows how investors could still…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How to invest £10,000 to aim for a £6,108 annual passive income

UK REITs have been getting a lot of attention. But our author thinks they're still the place to look for…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

What sort of passive income stream could you build for a fiver a day?

Think a few pounds a day might not go far? In fact, that could be the basis of some pleasing…

Read more »

British Isles on nautical map
Investing Articles

I sense a potential opportunity if the FTSE 100 loses this quality growth stock…

Rightmove falling out of the FTSE 100 might have been unthinkable a year ago. But that's the reality investors are…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

The largest S&P 500 holding in my ISA is…

Edward Sheldon's making a large bet on this S&P 500 stock. Because he sees the long-term risk/reward proposition very attractive.

Read more »